Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

Friday, October 30, 2009 General News J E 4

SEATTLE, Oct. 29 Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following upcoming investor conferences.

The presentations will be audio webcast live and available for replay from Dendreon's website,

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit

Merriman Investor Summit 2009 New York City Tuesday, November 10, 2009 11:00 a.m. ET Credit Suisse 2009 Healthcare Conference Phoenix, Arizona Friday, November 13, 2009 11:30 a.m. ET Lazard Capital Markets 6th Annual Healthcare Conference New York City Tuesday, November 17, 2009 10:55 a.m. ET

SOURCE Dendreon Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
The Ensign Group to Present at Oppenheimer 20th An...
MedCath Corporation to Hold Conference Call on Fou...